top of page

Developing transformative cancer medicines with CD19-Redirected ARTEMIS T Cells to improve patients’ lives

Frame 123.png

Estrella Innovations

Recent scientific breakthroughs in cell therapy have revealed potentials for patient care beyond hematological malignancies. Standing at the edge of the new frontier of malignant cancer treatments, we at Estrella are committed to translating scientific innovations into next-generation T-cell therapies that can address treatment challenges in both hematological malignancies and solid tumors.


Copy of IMG_8849-01.jpg

President and CEO


Chief Financial Officer

Scientific Advisory Board


Memorial Sloan Kettering Cancer Center


University of California, San Francisco


Children’s Hospital of Philadelphia (CHOP)

gianpietro-dotti-scaled (1)_edited.jpg

University of North Carolina

5 1.png

University of California, Berkeley



We are an energetic, science-driven team. We passionately pursue innovations that will help improve the lives of cancer patients. Our goal is to unlock the full potential of T-cell therapies and expand its curative power in both hematological malignancies and solid tumors. As we continue to grow, we are looking for curious, collaborative and entrepreneurial talents to join our team.


If you would like to be considered for a position at Estrella, please submit your resume and cover letter to

bottom of page